title: Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?
authors.forename: Omer
authors.initials: O
authors.lastname: Aras
authors.forename: Naomi Q
authors.initials: NQ
authors.lastname: Hanson
authors.forename: Michael Y
authors.initials: MY
authors.lastname: Tsai
authors.forename: Nigel S
authors.initials: NS
authors.lastname: Key
mesh_terms: D020016:Activated Protein C Resistance / Q000150:complications / Q000453:epidemiology* / Q000235:genetics; D000293:Adolescent; D019567:Back Injuries / Q000150:complications; D016022:Case-Control Studies; D004252:DNA Mutational Analysis; D005165:Factor V / Q000235:genetics*; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006239:Haplotypes / Q000235:genetics; D006720:Homozygote; D006801:Humans; D008297:Male; D016017:Odds Ratio; D011446:Prospective Studies; D012306:Risk; D012307:Risk Factors; D014682:Vena Cava, Inferior; D020246:Venous Thrombosis / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics
chemical_list: D005165:Factor V